Identifying and targeting FOLFIRINOX resistance mechanisms to improve outcomes in pancreatic cancer (#153)

5:40 PM

Katie Gordon

Welcome Reception & Poster Session 1

Temporally resolved proteomics identifies nidogen-2 as a co-target in pancreatic cancer that modulates fibrosis and therapy response (#235)

5:35 PM

Brooke Pereira

Poster Session 2

Pancreatic cancer secretome reveals PCSK9 as a co-target to sensitise tumours to chemotherapy and reduce metastasis (#244)

5:35 PM

Shona Ritchie

Poster Session 2

Targeting the NPY/NPY1R signaling axis impairs metastasis and tissue wasting in pancreatic cancer (#159)

5:40 PM

David Herrmann

Welcome Reception & Poster Session 1

Identifying and targeting treatment response mechanisms to improve Gemcitabine/Abraxane performance in Patient-Derived Models of Pancreatic Cancer (#263)

5:35 PM

Alice Tran

Poster Session 2

A phase I/II study to assess the toxicity and preliminary efficacy of SUBA-itraconazole and dual checkpoint inhibitor cadonilimab as maintenance therapy in advanced pancreatic ductal adenocarcinoma (#171)

5:40 PM

Bratati Karmakar

Welcome Reception & Poster Session 1

Targeting tumour fibrosis with a small molecule ROCK2 inhibitor to improve radiotherapy response in head and neck cancer (#276)

5:35 PM

Dannel Yeo

Poster Session 2

Deciphering netrin-1 implication in pancreatic cancer (#119)

5:40 PM

Nicolas Braissand

Welcome Reception & Poster Session 1